You are here

Article info

Article menu
Download PDFPDF
Commentary
Oral antiviral therapy for HBeAg negative chronic hepatitis B: better stop or continue?

Authors

  1. Correspondence to Dr Pietro Lampertico, 1st Division of Gastroenterology and Hepatology, “A.M. e A. Migliavacca” Center for the Study of Liver Disease, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via F. Sforza 35, Milan 20122, Italy; pietro.lampertico{at}unimi.it
View Full Text

Citation

Lampertico P
Oral antiviral therapy for HBeAg negative chronic hepatitis B: better stop or continue?
Gut 2015;64:526-528.

Publication history

  • Received July 28, 2014
  • Accepted July 28, 2014
  • First published August 20, 2014.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions